Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
2.130
-0.060 (-2.74%)
At close: Aug 28, 2026, 4:00 PM EDT
2.148
+0.018 (0.85%)
After-hours: Aug 28, 2026, 7:59 PM EDT
Tenax Therapeutics Employees
As of December 31, 2025, Tenax Therapeutics had 16 total employees, including 14 full-time and 2 part-time employees. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change (1Y)
10
Growth (1Y)
166.67%
Revenue / Employee
n/a
Profits / Employee
-$4,053,938
Market Cap
122.01M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | 10 | 166.67% | 14 | 2 |
| Dec 31, 2024 | 6 | 0 | - | 4 | 2 |
| Dec 31, 2023 | 6 | -2 | -25.00% | 5 | 1 |
| Dec 31, 2022 | 8 | -1 | -11.11% | 7 | 1 |
| Dec 31, 2021 | 9 | -1 | -10.00% | 8 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| enGene Therapeutics | 82 |
| Rani Therapeutics Holdings | 71 |
| Vivani Medical | 42 |
| Biomea Fusion | 37 |
| Aardvark Therapeutics | 28 |
| Genelux | 26 |
| Black Diamond Therapeutics | 21 |
TENX News
- 20 hours ago - Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 - GlobeNewsWire
- 13 days ago - TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law - Business Wire
- 16 days ago - TENX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Tenax Therapeutics - PRNewsWire
- 18 days ago - Tenax Therapeutics downgraded to Neutral from Buy at Chardan - TheFly
- 18 days ago - Tenax Therapeutics price target lowered to $4 from $35 at Canaccord - TheFly
- 18 days ago - Tenax Therapeutics price target lowered to $4 from $40 at Guggenheim - TheFly
- 18 days ago - Tenax Therapeutics price target lowered to $4 from $26 at Leerink - TheFly
- 19 days ago - Tenax Therapeutics downgraded to In Line from Outperform at Evercore ISI - TheFly